Table 1.

Demographic and clinical characteristics of survey respondents (N = 915–969)

Study variable	Data source	Response	(N)	%
Gender (n = 969)	Survey	Female	474	48.9
Age at survey (n = 969)	Survey	< 45 years	380	39.2
		45–54 years	240	24.8
		55–64 years	229	23.6
		65 + years	120	12.4
Race (n = 953)	Survey	White	186	19.5
		Black	95	10.0
		Asian/Pacific Islander	672	70.5
Hispanic (n = 953)	Survey	Yes	17	1.8
Born in U.S. or Canada (n = 959)	Survey	Yes	323	33.7
Married (n = 955)	Survey	Yes	672	70.4
Annual income (n = 957)	EHR	Less than $30 K	95	9.9
		$30–49 K	343	35.8
		$50 K or More	519	54.2
Education (n = 925)	Survey	Less than high school	121	13.1
		High School/GED	129	13.9
		Some College	234	25.3
		College Grad/Higher	441	47.7
Employment (n = 950)	Survey	Full/part-time	659	69.4
Health insurance (n = 952)	EHR	Medicaid	64	6.7
		Medicare	202	21.2
		Private	686	72.1
Life stressors (n = 969)	Survey	No stress	625	64.5
		Moderate stress	222	22.9
		High stress	122	12.6
Social support (n = 969)	Survey	Low support	340	35.1
		Moderate support	232	23.9
		High support	397	41.0
History of injection drug use (n = 969)	Survey	Yes	25	2.6
Ever in drug abuse treatment (n = 951)	Survey	Yes	29	3.0
Ever in alcohol abuse treatment (n = 966)	Survey	Yes	33	3.4
Current alcohol abuse [26, 27] (n = 953)	Survey	Yes	113	11.9
Current cigarette smoker (n = 952)	Survey	Yes	102	10.7
HBV treatment naive (n = 915)	Survey	Yes	369	40.3
On HBV medications past 4 weeks (n = 964)	Survey	Yes	271	28.2
Stopped HBV meds past 12 months (n = 963)	Survey	No	282	77.7
		Yes	81	22.3
		Not applicablea	600	–
Ever visited hepatologist (n = 938)	Survey	Yes	710	75.7
Ever liver transplant (n = 969)	EHR	Yes	16	16.5
Cirrhosis (n = 969)	EHR	Yes	16	1.7
Charlson comorbidity score [33] (n = 969)	EHR	Score of 0	707	73.0
		Score of 1	132	13.6
		Score of ≥ 2	130	13.4
SF-8 mental component score [16, 17] (n = 969)	Survey	Mean ± SD	51.3 ± 8.9
SF8 physical component score [16, 17] (n = 969)	Survey	Mean ± SD	51.0 ± 8.6

^aPatients have not started any drugs for hepatitis B